Hepcidin Behavior in Patients With Obesity and Bariatric Surgery

Study Overview
=================
Brief Summary
-----------------
Iron deficiency is one of the most common nutritional problems observed in patients with obesity and after bariatric surgery. From a therapeutic point of view, iron deficiency can lead to iron deficiency anemia. Iron supplementation carries the risk of exacerbating infections, altering the gut microbiome and iron overload. Therefore, it would be beneficial to use iron supplementation only in truly iron deficient patients. To date, different studies have observed that hepcidin could be a possible indicator of iron status and absorption in different patient populations. Furthermore, it could be used to distinguish anemia due to iron deficiency from inflammation and globin disorder related anemia. How hepcidin concentrations variate in patients with obesity and after bariatric surgery remains unsure.

Detailed Description
-----------------
During the visit in the obesity clinic, eligible patients will be approached for participation by the sub-investigator. Interested patients will receive information regarding the study and receive the information sheet containing the informed consent form. After signing the informed consent form, general information will be collected regarding medical and demographic data using a short questionnaire. Additional questionnaires regarding demographics and menstrual cycle will be collected. Anthropometric measurements will be collected for the determination of the length, weight, hip circumference, waist circumference and body composition. Finally, blood samples will be collected for the determination of iron and inflammation related markers.

Official Title
-----------------
Hepcidin Behavior in Patients With Obesity and Bariatric Surgery

Conditions
-----------------
Hepcidin

Intervention / Treatment
-----------------
* Other: Blood sampling


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: The patient has to be 18 years or older Written informed consent has to be obtained after being informed on all aspects of the study The patient has a BMI > 30 kg/m² OR There has to be at least one year between the primary RYGB and the participation in the study OR There has to be at least one year between the primary SG and the participation in the study Exclusion Criteria: Patients younger than 18 years old Women who are pregnant or are breastfeeding Post-menopausal women, defined as at least 6 months of amenorrhea after the final menstrual period Inability to follow the procedures of the studies due to language problems Patients who have had more than one bariatric surgery

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients with obesity<br>In 100 patients with obesity, blood samples will be collected. | Other: Blood sampling<br>* Blood sample collection<br>|
| Patients with a Sleeve Gastrectomy<br>In 100 patients with a Sleeve Gastrectomy, blood samples will be collected. | Other: Blood sampling<br>* Blood sample collection<br>|
| Patients with a Roux-en-Y Gastric Bypass<br>In 100 patients with a Roux-en-Y Gastric Bypass, blood samples will be collected. | Other: Blood sampling<br>* Blood sample collection<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Serum hepcidin concentration | Serum hepcidin concentration | Study visit 1 day | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Hemoglobin concentration | Hemoglobin concentration | Study visit 1 day | 
| Mean corpuscular volume | Mean corpuscular volume | Study visit 1 day | 
| Iron concentration | Iron concentration | Study visit 1 day | 
| Ferritin concentration | Ferritin concentration | Study visit 1 day | 
| Transferrin concentration | Transferrin concentration | Study visit 1 day | 
| Transferrin saturation | Transferrin saturation | Study visit 1 day | 
| C-reactive protein | C-reactive protein | Study visit 1 day | 
| Vitamin B12 concentration | Vitamin B12 concentration | Study visit 1 day | 
| Folate (RBC level) | Folate (RBC level) | Study visit 1 day | 
| Folate (serum level) | Folate (serum level) | Study visit 1 day |